SCHEMBL13680468

SCHEMBL13680468

Cc1cccc(-c2ccc(F)nc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.53
GRIN2B Q13224 1/20 0.53
ACHE P22303 1/20 0.47
CYP11B2 P19099 1/20 0.45
CYP2A6 P11509 3/20 0.45
CYP2B6 P20813 3/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2E1 P05181 1/20 0.44
NR3C1 P04150 1/20 0.44
SYK P43405 1/20 0.44
MAP4K4 O95819 2/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ENPP3 O14638 1/20 0.42
IDO1 P14902 1/20 0.42
METAP2 P50579 1/20 0.42
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404645 0.81 HSD17B1 (0.55) ACHEMAP4K4RAB9AENPP3IDO1
SCHEMBL2757248 0.81 MAP4K4 (0.46) ACHEMAP4K4RAB9AENPP3IDO1
SCHEMBL12947816 0.78 CYP2A6 (0.52) ACHECYP11B2CYP2A6CYP2B6CYP3A4
SCHEMBL30098552 0.78 MAP4K4 (0.68) CYP11B2CYP2A6CYP2B6CYP3A4CYP2E1
SCHEMBL21410258 0.78 CYP11B2 (0.45) GRIN1GRIN2BCYP11B2CYP2A6CYP2B6
SCHEMBL20098737 0.78 MAP4K4 (0.44) GRIN1GRIN2BACHEMAP4K4RAB9A
SCHEMBL4406991 0.78 HSD17B1 (0.51) ACHEMAP4K4RAB9AENPP3IDO1
SCHEMBL12349144 0.78 MAP4K4 (0.68) MAP4K4RAB9ANPC1TP53SMN1; SMN2
SCHEMBL11158811 0.78 CYP2A6 (0.55) CYP2A6MAP4K4RAB9ANPC1SMN1; SMN2
SCHEMBL32663642 0.78 CYP2A6 (0.55) CYP2A6MAP4K4RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed